Clinical Research Directory
Browse clinical research sites, groups, and studies.
Non-Invasive Diagnosis and Monitoring of Cardiac Masses by Liquid Biopsy
Sponsor: Niguarda Hospital
Summary
This is a nonprofit, observational, prospective and retrospective,multicenter study in a population of young and adult patients ≥12 years with a diagnosis of a cardiac mass. The study will include both patients with masses of unknown pathological diagnosis and patients with a known histology of benign or malignant tumors. We predict a case-control allocation ratio of 1:1 between cardiac malignant tumors and benign lesions. Peripheral blood will be collected at participating centers during routine venipuncture,processed and then shipped for liquid biopsy ctDNA NGS analyses. If available, in malignant cases, matched tumor tissue samples collected as per clinical practice solid biopsies or surgery will be used for analyses. Longitudinal tracking through serial blood draws could be performed in selected cases of patients with cardiac malignancies who receive cancer treatment
Official title: Non-Invasive Diagnosis and Monitoring of Cardiac Masses by Liquid Biopsy: The CarMA Study
Key Details
Gender
All
Age Range
12 Years - Any
Study Type
OBSERVATIONAL
Enrollment
26
Start Date
2024-07-25
Completion Date
2025-12-25
Last Updated
2025-11-19
Healthy Volunteers
No
Conditions
Interventions
NGS-guided regimen: Regimen A
Liquid biopsy, consisting of a venous blood sample, will be collected during routine venipuncture
Locations (1)
Niguarda Hospital
Milan, Italia, Italy